Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

620 ARTÍCULOS , VIENDO DEL 331 AL 345

Multi-Target Directed Ligands (MTDLs): Promising Coumarin Hybrids for Alzheimer's Disease

Bhatia R, Chakrabarti SS, Kaur U, Parashar G, Banerjee A, Rawal RK.

Curr Alzheimer Res. 2021;18(10):802-830. doi: 10.2174/1567205018666211208140551.

Applied machine learning in Alzheimer's disease research: omics, imaging, and clinical data

Li Z, Jiang X, Wang Y, Kim Y.

Emerg Top Life Sci. 2021 Dec 21;5(6):765-777. doi: 10.1042/ETLS20210249.

What have we learned from past failures of investigational drugs for Alzheimer's disease?

Imbimbo BP, Watling M.

Expert Opin Investig Drugs. 2021 Dec;30(12):1175-1182. doi: 10.1080/13543784.2021.2017881. Epub 2021 Dec 20.

Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction

Moss DE, Perez RG.

Curr Alzheimer Res. 2021;18(13):1010-1022. doi: 10.2174/1567205018666211215150547.

Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia

Mühlbauer V, Möhler R, Dichter MN, Zuidema SU, Köpke S, Luijendijk HJ.

Cochrane Database Syst Rev. 2021 Dec 17;12(12):CD013304. doi: 10.1002/14651858.CD013304.pub2.

Small Molecule Drugs Targeting Non-Coding RNAs as Treatments for Alzheimer's Disease and Related Dementias

Nguyen LD, Chau RK, Krichevsky AM.

Genes (Basel). 2021 Dec 17;12(12):2005. doi: 10.3390/genes12122005.

Computer-Based Drug Design of Positive Modulators of Store-Operated Calcium Channels to Prevent Synaptic Dysfunction in Alzheimer's Disease

Hunanyan L, Ghamaryan V, Makichyan A, Popugaeva E.

Int J Mol Sci. 2021 Dec 19;22(24):13618. doi: 10.3390/ijms222413618.

Probiotics for Alzheimer's Disease: A Systematic Review

Naomi R, Embong H, Othman F, Ghazi HF, Maruthey N, Bahari H.

Nutrients. 2021 Dec 22;14(1):20. doi: 10.3390/nu14010020.

Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's disease

Fang J, Zhang P, Zhou Y, Chiang CW, Tan J, Hou Y, Stauffer S, Li L, Pieper AA, Cummings J, Cheng F.

Nat Aging. 2021 Dec;1(12):1175-1188. doi: 10.1038/s43587-021-00138-z. Epub 2021 Dec 6.

Aducanumab and the FDA - where are we now?

Fillit H, Green A.

Nat Rev Neurol. 2021 Mar;17(3):129-130. doi: 10.1038/s41582-020-00454-9.

Aspirin in people with dementia, long-term benefits, and harms: a systematic review

Davis KAS, Bishara D, Molokhia M, Mueller C, Perera G, Stewart RJ.

Eur J Clin Pharmacol. 2021 Jul;77(7):943-954. doi: 10.1007/s00228-021-03089-x. Epub 2021 Jan 22.

Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease

Joseph-Mathurin N, Wang G, Kantarci K, Jack CR Jr, McDade E, Hassenstab J, Blazey TM, Gordon BA, Su Y, Chen G, Massoumzadeh P, Hornbeck RC, Allegri RF, Ances BM, Berman SB, Brickman AM, Brooks WS, Cash DM, Chhatwal JP, Chui HC, Correia S, Cruchaga C, Farlow MR, Fox NC, Fulham M, Ghetti B, Graff-Radford NR, Johnson KA, Karch CM, Laske C, Lee AKW, Levin J, Masters CL, Noble JM, O'Connor A, Perrin RJ, Preboske GM, Ringman JM, Rowe CC, Salloway S, Saykin AJ, Schofield PR, Shimada H, Shoji M, Suzuki K, Villemagne VL, Xiong C, Yakushev I, Morris JC, Bateman RJ, Benzinger TLS; Dominantly Inherited Alzheimer Network.

Neurology. 2021 Mar 23;96(12):e1632-e1645. doi: 10.1212/WNL.0000000000011542. Epub 2021 Jan 25.

Alzheimer's Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation

Lehmann L, Lo A, Knox KM, Barker-Haliski M.

Neurochem Res. 2021 Aug;46(8):1895-1912. doi: 10.1007/s11064-021-03332-y. Epub 2021 Apr 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias